DelveInsight launched a new report on Shigella Infections – Market Insights, Epidemiology, and Market Forecast-2030
DelveInsight’s “Shigella Infections Market” report delivers an in-depth understanding of the Shigella Infections, historical and forecasted epidemiology as well as the Shigella Infections market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The key fact of the report:
“Shigella infections or Shigellosis causes approximately 450,000 cases of diarrhoea in the United States annually.”
Key benefits of the report:
1. Shigella infections market report covers a descriptive overview and comprehensive insight of the Shigella infections epidemiology and Shigella infections market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Shigella infections market report provides insights on the current and emerging therapies.
3. Shigella infections market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Shigella infections market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Shigella infections market.
View full report: https://www.delveinsight.com/report-store/shigella-infections-market
The key players in Shigella infections market are:
1. LimmaTech Biologics AG
2. GlaxoSmithKline
3. Immuron
The launch of the emerging therapies is expected to significantly impact Shigella infections treatment scenario in the upcoming years:-
Drugs covered:
1. GSK3536852A
and others
Table of contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Shigellosis Patient Share (%) Overview at a Glance
5. Shigella infections Market Overview at a Glance
6. Shigella infections Disease Background and Overview
7. Shigella infections Epidemiology and Patient Population
8. Country-Specific Patient Population of Shigellosis
8.1. United States
8.2. EU5
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. Spain
8.2.5. United Kingdom
8.3. Japan
9. Current Shigella infections Treatment and Medical Practices
10. Unmet Needs
11. Shigella infections Emerging Therapies
12. Key Cross Competition
12.1. GSK3536852A: GlaxoSmithKline
13. Shigellosis Market Outlook
14. Country-Wise Market Analysis (2017–2030)
14.1. United States Market Size
14.2. Germany Market Size
14.3. France Market Size
14.4. Italy Market Size
14.5. Spain Market Size
14.6. United Kingdom Market Size
14.7. Japan Market Size
15. Market Access and Reimbursement of Therapies
16. Market drivers
17. Market barriers
18. Appendix
19. Report Methodology
20. DelveInsight Capabilities
21. Disclaimer
22. About DelveInsight
Related reports:
Shigella Infections – Epidemiology Forecast to 2030
Shigella Infections Pipeline Insight, 2020
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
